|
WO2020163416A1
|
|
Devices and methods for tobramycin inhalation treatment
|
|
WO2020072582A1
|
|
Medication packaging and dose regimen system
|
|
WO2020072568A1
|
|
Medication packaging and dose regimen system
|
|
CA3105212A1
|
|
Pregabalin extended-release formulations
|
|
US2020001026A1
|
|
Smart spacer for an inhaler
|
|
US2019034862A1
|
|
Inventory Control System
|
|
US2020121870A1
|
|
Low-cost single use powder inhaler
|
|
AU2018261206A1
|
|
Medical home reminder unit and system
|
|
CA3033719A1
|
|
Child resistant medication packaging
|
|
CA3031421A1
|
|
View window medication packaging
|
|
WO2017180980A1
|
|
Systems, devices and methods for assessing inhalation therapy
|
|
CN109152746A
|
|
Double-arc spline Transdermal System
|
|
CN108024905A
|
|
Drug packages and dosage regimen system
|
|
EP3355863A1
|
|
Stable formulations of fingolimod
|
|
US2017290779A1
|
|
Double disk transdermal process
|
|
US2019046449A1
|
|
A unique high-shear granulation process for improved bioavailability of rivaroxaban
|
|
US2019125678A1
|
|
Sustained-Release Oral Dosage Forms for Low Aqueous Solubility Compounds
|
|
CA2974661A1
|
|
Medication packaging and dose regimen system
|
|
AU2015363073A1
|
|
System and method for medicament storage, dispensing, and administration
|
|
AU2015315181A1
|
|
Medication delivery system and method
|
